9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine
Modify Date: 2024-08-09 18:22:54
9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine structure
|
Common Name | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine | ||
|---|---|---|---|---|
| CAS Number | 1347118-41-5 | Molecular Weight | 416.82 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 592.2±60.0 °C at 760 mmHg | |
| Molecular Formula | C19H17ClN4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 312.0±32.9 °C | |
Use of 9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 9-(2-O-Acetyl-5-O-benzoyl-3-deoxy-β-D-erythro-pentofuranosyl)-6-chloro-9H-purine |
|---|---|
| Synonym | More Synonyms |
| Description | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 592.2±60.0 °C at 760 mmHg |
| Molecular Formula | C19H17ClN4O5 |
| Molecular Weight | 416.82 |
| Flash Point | 312.0±32.9 °C |
| Exact Mass | 416.088745 |
| LogP | 2.60 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.686 |
| 9-(2-O-Acetyl-5-O-benzoyl-3-deoxy-β-D-erythro-pentofuranosyl)-6-chloro-9H-purine |
| 9H-Purine, 9-(2-O-acetyl-5-O-benzoyl-3-deoxy-β-D-erythro-pentofuranosyl)-6-chloro- |